Further Health Technology Assessments

In addition to our TAR and ESG programmes of work we also undertake further HTAs directly funded by the National Institute of Health and Care Research (NIHR) and other organisations:

Ablative and non-invasive therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis

Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation

Interventions based on early intensive applied behaviour analysis for autistic children: a systematic review and cost-effectiveness analysis

Imaging tests for the detection of osteomyelitis: a systematic review

Interventional management of hyperhidrosis: a systematic review and value of information analysis

IPD meta-analysis evaluating progestogen for prevention of preterm birth